398 related articles for article (PubMed ID: 14535988)
21. Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion.
Andreola F; Calvisi DF; Elizondo G; Jakowlew SB; Mariano J; Gonzalez FJ; De Luca LM
Hepatology; 2004 Jan; 39(1):157-66. PubMed ID: 14752834
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
24. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing.
Hao J; Ju H; Zhao S; Junaid A; Scammell-La Fleur T; Dixon IM
J Mol Cell Cardiol; 1999 Mar; 31(3):667-78. PubMed ID: 10198196
[TBL] [Abstract][Full Text] [Related]
25. TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.
Argentou N; Germanidis G; Hytiroglou P; Apostolou E; Vassiliadis T; Patsiaoura K; Sideras P; Germenis AE; Speletas M
Inflamm Res; 2016 May; 65(5):355-65. PubMed ID: 26856334
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.
Walraven M; Beelen RH; Ulrich MM
J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202
[TBL] [Abstract][Full Text] [Related]
27. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
28. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
29. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.
Romero-Gallo J; Sozmen EG; Chytil A; Russell WE; Whitehead R; Parks WT; Holdren MS; Her MF; Gautam S; Magnuson M; Moses HL; Grady WM
Oncogene; 2005 Apr; 24(18):3028-41. PubMed ID: 15735717
[TBL] [Abstract][Full Text] [Related]
31. Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.
Inagaki Y; Kushida M; Higashi K; Itoh J; Higashiyama R; Hong YY; Kawada N; Namikawa K; Kiyama H; Bou-Gharios G; Watanabe T; Okazaki I; Ikeda K
Gastroenterology; 2005 Jul; 129(1):259-68. PubMed ID: 16012952
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling.
Zhang XL; Topley N; Ito T; Phillips A
J Biol Chem; 2005 Apr; 280(13):12239-45. PubMed ID: 15661740
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
34. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.
König HG; Kögel D; Rami A; Prehn JH
J Cell Biol; 2005 Mar; 168(7):1077-86. PubMed ID: 15781474
[TBL] [Abstract][Full Text] [Related]
35. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
Chen A
Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
[TBL] [Abstract][Full Text] [Related]
36. Corticosteroids stimulate selectively transforming growth factor (TGF)-beta receptor type III expression in transdifferentiating hepatic stellate cells.
Wickert L; Abiaka M; Bolkenius U; Gressner AM
J Hepatol; 2004 Jan; 40(1):69-76. PubMed ID: 14672616
[TBL] [Abstract][Full Text] [Related]
37. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.
Sakai K; Jawaid S; Sasaki T; Bou-Gharios G; Sakai T
Am J Pathol; 2014 Oct; 184(10):2611-7. PubMed ID: 25108224
[TBL] [Abstract][Full Text] [Related]
39. Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
Fernandez T; Amoroso S; Sharpe S; Jones GM; Bliskovski V; Kovalchuk A; Wakefield LM; Kim SJ; Potter M; Letterio JJ
J Exp Med; 2002 May; 195(10):1247-55. PubMed ID: 12021305
[TBL] [Abstract][Full Text] [Related]
40. Effect of ginseng extract on the TGF-β1 signaling pathway in CCl
Hafez MM; Hamed SS; El-Khadragy MF; Hassan ZK; Al Rejaie SS; Sayed-Ahmed MM; Al-Harbi NO; Al-Hosaini KA; Al-Harbi MM; Alhoshani AR; Al-Shabanah OA; Alsharari SD
BMC Complement Altern Med; 2017 Jan; 17(1):45. PubMed ID: 28086769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
